S. ALTANER ET AL.
Copyright © 2013 SciRes. SS
376
Infection,” Grune and Stratton, New York, 1975.
[5] A. Saxena, “Rheumatic Fever and Long-Term Sequelae
in Children,” Current Treatment Options in Cardiovas-
cular Medicine, Vol. 4, No. 4, 2002, pp. 309-319.
doi:10.1007/s11936-002-0011-7
[6] World Health Organization, “Rheumatic Fever and Rheu-
matic Heart Disease,” Report of an Expert Panel, Geneva,
2004.
[7] J. C. Rowe, F. Bland, H. B. Sprague and P. D. White,
“Course of Mitral Stenosis without Surgery: 10 and 20
Years Perspectives,” Annals of Internal Medicine, Vol. 52,
No. 4, 1960, pp. 741-749.
doi:10.7326/0003-4819-52-4-741
[8] E. L. Kaplan, “Pathogenesis of Acute Rheumatic Fever
and Rheumatic Heart Disease: Evasive after Half a Cen-
truy of Clinical, Epidemiological, and Laboratory Inves-
tigation,” Heart, Vol. 91, 2005, pp. 3-4.
doi:10.1136/hrt.2004.034744
[9] L. L. Minich, L. Y. Tani, L. T. Pagotto, R. E. Shaddy and
L. G. Veasy, “Doppler Echocardiography Distinguishes
between Silent Mitral Regurgitation in Patients with
Rheumatic Fever,” Clinical Cardiology, Vol. 20, No. 11,
1997, pp. 924-926. doi:10.1002/clc.4960201105
[10] W. Doerr, W. Giese, L. D. Leder and W. Remmele, “Organ-
pathologie, Band I: Herz und Gefäße, Blut und Blut-
bereitende Organe, Atemwege und Lungen,” Georg
Thieme Verlag, Stuttgart, 1974.
[11] S. J. Weiss, “Tissue Destruction by Neutrophils,” The
New England Journal of Medicine, Vol. 320, No. 6, 1989,
pp. 365-376. doi:10.1056/NEJM198902093200606
[12] H. A. Papadaki, “Cell Adhesion Molecules in Haema-
tology,” Haema, Vol. 2, 1999, pp. 180-191.
[13] T. A. Springer, “Adhesion Receotors of the Immune Sys-
tem,” Nature, Vol. 346, No. 6283, 1990, pp. 425-434.
doi:10.1038/346425a0
[14] R. Piggot and W. Newman, “Circulating Adhesion Mole-
cules in Disease,” Immunology Today, Vol. 14, No. 10,
1993, pp. 506-512. doi:10.1016/0167-5699(93)90267-O
[15] M. J. Elices, L. Osborn, Y. Takada, C. Crouse, S. Lu-
howskj, M. E. Hemler and R. R. Lobb, “VCAM-1 on Ac-
tivated Endothelium Interacts with the Leucocytes In-
tegrin VLA-4 at the Site Distinct from VLA-4/Fibronec-
tin Binding Site,” Cell, Vol. 60, No. 4, 1990, pp. 577-584.
doi:10.1016/0092-8674(90)90661-W
[16] C. H. Shahi, N. K. Ghasias, M. Goggins, B. Foley, P.
Crean, D. Kelleher and M. Walsh, “Elevated Levels of
Circulating Soluble Adhesion Molecules in Patients with
Nonrheumatic Aortic Stenosis,” American Journal of
Cardiology, Vol. 79, No. 7, 1997, pp. 980-982.
doi:10.1016/S0002-9149(97)00027-1
[17] N. K. Ghaisas, J. B. Foley, D. S. O’Briain, P. Crean, D.
Kelleher and M. Walsh, “Adhesion Molecules in Non-
rheumatic Aortic Valve Disease: Endothelial Expressio,
Serum Levels and Effects of Valve Replacement,” Jour-
nal of the American College of Cardiology, Vol. 36, No.
7, 2000, pp. 2257-2262.
doi:10.1016/S0735-1097(00)00998-0
[18] E. Yetkin, A. R. Erbay, M. Ileri, H. Turhan, M. Balci, S.
Çehreli, G. Yetkin and D. Demirkan, “Levels of Circu-
lating Adhesion Molecules in Rheumatic Mitral Steno-
sis,” American Heart Journal, Vol. 88, No. 10, 2001, pp.
1209-1211.
[19] N. Patey, P. Lesavre, L. Halbwaschs-Macarelli and L. H.
Noel, “Adhesion Molecules in Human Cresentric Glome-
rulojnephritis,” The Journal of Pathology, Vol. 179, No. 4,
1996, pp. 414-420.
doi:10.1002/(SICI)1096-9896(199608)179:4<414::AID-P
ATH601>3.0.CO;2-J
[20] B. I. Tropea, P. Huie, J. P. Cooke, P. S. Tsao, R. K. Sibley
and C. K. Zarins, “Hypertension-Enhanced Monocyte Ad-
hesion in Experimental Atherosclerosis,” Journal of Vas-
cular Surgery, Vol. 23, No. 4, 1996, pp. 596-605.
doi:10.1016/S0741-5214(96)80038-3
[21] A. H. J. Gearing and W. Newman, “Circulating Adhesion
Molecules in Disease,” Immunology Today, Vol. 14, 1993,
pp. 506-512. doi:10.1016/0167-5699(93)90267-O
[22] C. M. Ballantyne, E. A. Mainolfi, J. B. Young, N. T.
Windsor, B. Cocanougher, E. C. Lawrence, M. S. Polack,
M. L. Entman and R. Rothlein, “Relationship of Increased
Levels of Circulating Intercellular Adhesion 1 after Heart
Transplantation to Rejection: Human Leucocyte Antigen
Mismatch and Survival,” The Journal of Heart and Lung
Transplantation, Vol. 13, No. 4, 1994, pp. 597-603.
[23] K. Nakai, C. Itoh, K. Kawazoe, Y. Miura, H. Sotyanagi,
K. Hotta, T. Itoh, J. Kamata and K. Hiramori, “Concen-
tration of Soluble Vascular Adesion Molecule-1 Corre-
lated with Expression of VCAM-1 mRNA in Human
Atherosclerotic Aorta,” Coronary Artery Disease, Vol. 6,
No. 6, 1996, pp. 497-502.
[24] E. Yetkin, A. R. Erbay, H. Turhan, M. Balci, F. Yetkin, G.
Yetkin, M. Ileri, K. Senen, R. Atak and S. Cehreli,
“Changes in Plasma Levels of Adhesion Molecules after
Percutaneous Mitral Balloon Valvuloplasty,” Cardiovas-
cular Pathology, Vol. 13, No. 2, 2004, pp. 103-108.
doi:10.1016/S1054-8807(03)00128-5
[25] M. C. Chen, H. W. Chang, S. S. Juang, H. K. Yip, C. J.
Wu, T. H. Yu and C. I. Cheng, “Percutaneous Translu-
minal mitral Valvuloplasty Reduces Circulating Vascular
Cell Adhesion Molecule-1 in Rheumatic Mitral Stenosis,”
Chest, Vol. 125, No. 4, 2004, pp. 1213-1217.
doi:10.1378/chest.125.4.1213
[26] A. M. Muller, C. Cronen, L. I. Kupferwasser, H. Oelert,
K. M. Muller and C. J. Kirkpatrick, “Expression of En-
dothelial Cell Adhesion Molecules on Heart Valves:
Up-Regulation in Degeneration As Well As Acute Endo-
carditis,” The Journal of Pathology, Vol. 191, No. 1,
2000, pp. 54-60.
doi:10.1002/(SICI)1096-9896(200005)191:1<54::AID-P
ATH568>3.0.CO;2-Y
[27] L. Wallby, B. Janerot-Sjöberg, T. Steffensen and M. Bro-
qvist, “T Lymphocyte Infiltration in Non-Rheumatic Aor-
tic Stenosis: A Comparative Descriptive Study between
Tricuspid and Bicuspid Aortic Valves,” Heart, Vol. 88,
2002, pp. 348-351. doi:10.1136/heart.88.4.348